Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulation
Introduction Use of combined antidepressive treatment included high-frequency rhythmic transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (DLPFC) is one of the ways for overcoming of pharmaco-resistance in depressive patients. Objectives The aim of the study was...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2021-04-01
|
| Series: | European Psychiatry |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821003084/type/journal_article |
| _version_ | 1797616129853620224 |
|---|---|
| author | E. Iznak A. Iznak I. Oleichik |
| author_facet | E. Iznak A. Iznak I. Oleichik |
| author_sort | E. Iznak |
| collection | DOAJ |
| description |
Introduction
Use of combined antidepressive treatment included high-frequency rhythmic transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (DLPFC) is one of the ways for overcoming of pharmaco-resistance in depressive patients.
Objectives
The aim of the study was the search for possible EEG predictors of antidepressive effects of rTMS of the left DLPFC in combined treatment of depression.
Methods
30 female in-patients (F31.3, F33.0, F33.1, by ICD-10; 20-50 years, mean age 36.9±10.3) with pharmaco-resistant depression were enrolled in the study. Treatment included antidepressants (mainly SSRI) and a 3-week course of rTMS (20 Hz) of the left DLPFC. Correlations between pre-treatment EEG spectral power values, and post-treatment quantitative clinical assessments of patients were analyzed. Responders/non-responders were determined by standard criteria of 50% decrease in HDRS-17 scale total scores after treatment course.
Results
Responders (23 out of 30) revealed significant (p<0.05) negative correlations between post-treatment HDRS-17 scores and pre-treatment EEG spectral power in theta-2 (6-8 Hz) and alpha-1 (8-9 Hz) frequency sub-bands in the parietal-occipital-posterior temporal leads. Non-responders (7 out of 30) showed negative correlations between the post-treatment HDRS-17 scores and pre-treatment theta-2 EEG spectral power in the frontal-central-temporal regions of the right hemisphere.
Conclusions
Even brief course of rTMS of the left DLPFC enhances the action of antidepressants, and allows overcoming partially the pharmaco-resistance in depressive patients. Baseline values of theta-2 and alpha-1 EEG spectral power may serve as possible predictors of the effects of combined antidepressive therapy including rTMS. The study supported by RBRF grant No.18-01-00029a.
Disclosure
No significant relationships.
|
| first_indexed | 2024-03-11T07:36:54Z |
| format | Article |
| id | doaj.art-5cb527aa5dd445e8b8c5efb463620a15 |
| institution | Directory Open Access Journal |
| issn | 0924-9338 1778-3585 |
| language | English |
| last_indexed | 2024-03-11T07:36:54Z |
| publishDate | 2021-04-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj.art-5cb527aa5dd445e8b8c5efb463620a152023-11-17T05:09:16ZengCambridge University PressEuropean Psychiatry0924-93381778-35852021-04-0164S106S10710.1192/j.eurpsy.2021.308Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulationE. Iznak0A. Iznak1I. Oleichik2Laboratory Of Neurophysiology, Mental Health Research Centre, Moscow, Russian FederationLaboratory Of Neurophysiology, Mental Health Research Centre, Moscow, Russian FederationClinical Department Of Endogenous Mental Disorders And Affective States, Mental Health Research Centre, Moscow, Russian Federation Introduction Use of combined antidepressive treatment included high-frequency rhythmic transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (DLPFC) is one of the ways for overcoming of pharmaco-resistance in depressive patients. Objectives The aim of the study was the search for possible EEG predictors of antidepressive effects of rTMS of the left DLPFC in combined treatment of depression. Methods 30 female in-patients (F31.3, F33.0, F33.1, by ICD-10; 20-50 years, mean age 36.9±10.3) with pharmaco-resistant depression were enrolled in the study. Treatment included antidepressants (mainly SSRI) and a 3-week course of rTMS (20 Hz) of the left DLPFC. Correlations between pre-treatment EEG spectral power values, and post-treatment quantitative clinical assessments of patients were analyzed. Responders/non-responders were determined by standard criteria of 50% decrease in HDRS-17 scale total scores after treatment course. Results Responders (23 out of 30) revealed significant (p<0.05) negative correlations between post-treatment HDRS-17 scores and pre-treatment EEG spectral power in theta-2 (6-8 Hz) and alpha-1 (8-9 Hz) frequency sub-bands in the parietal-occipital-posterior temporal leads. Non-responders (7 out of 30) showed negative correlations between the post-treatment HDRS-17 scores and pre-treatment theta-2 EEG spectral power in the frontal-central-temporal regions of the right hemisphere. Conclusions Even brief course of rTMS of the left DLPFC enhances the action of antidepressants, and allows overcoming partially the pharmaco-resistance in depressive patients. Baseline values of theta-2 and alpha-1 EEG spectral power may serve as possible predictors of the effects of combined antidepressive therapy including rTMS. The study supported by RBRF grant No.18-01-00029a. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S0924933821003084/type/journal_articletranscranial magnetic stimulationbaseline EEGprediction of treatment effectspharmaco-resistant depression |
| spellingShingle | E. Iznak A. Iznak I. Oleichik Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulation European Psychiatry transcranial magnetic stimulation baseline EEG prediction of treatment effects pharmaco-resistant depression |
| title | Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulation |
| title_full | Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulation |
| title_fullStr | Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulation |
| title_full_unstemmed | Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulation |
| title_short | Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulation |
| title_sort | baseline eeg correlates of responders non responders to combined antidepressive treatment including transcranial magnetic stimulation |
| topic | transcranial magnetic stimulation baseline EEG prediction of treatment effects pharmaco-resistant depression |
| url | https://www.cambridge.org/core/product/identifier/S0924933821003084/type/journal_article |
| work_keys_str_mv | AT eiznak baselineeegcorrelatesofrespondersnonresponderstocombinedantidepressivetreatmentincludingtranscranialmagneticstimulation AT aiznak baselineeegcorrelatesofrespondersnonresponderstocombinedantidepressivetreatmentincludingtranscranialmagneticstimulation AT ioleichik baselineeegcorrelatesofrespondersnonresponderstocombinedantidepressivetreatmentincludingtranscranialmagneticstimulation |